Cellectis Sa Stock Performance
| CLLS Stock | USD 3.90 0.09 2.26% |
The firm shows a Beta (market volatility) of 0.55, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cellectis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cellectis is expected to be smaller as well. At this point, Cellectis SA has a negative expected return of -0.42%. Please make sure to confirm Cellectis' downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Cellectis SA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cellectis SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return (0.76) | Five Day Return 5.12 | Year To Date Return (18.75) | Ten Year Return (82.41) | All Time Return (90.60) |
1 | Will Cellectis S.A. stock return to pre crash levels - July 2025 Recap Capital Protection Trade Alerts - Newser | 12/02/2025 |
2 | ASH 2025 Cellectis prsente son plan de dveloppement pour renforcer les taux de rponse levs obtenus avec ti-cel dans le LNH en rechute ou rfractaire | 12/08/2025 |
3 | 3 European Penny Stocks With Market Caps Under 400M | 12/11/2025 |
4 | Cellectis Showcasing Encouraging Data, But Still Early To Make A Run Like This - Seeking Alpha | 12/18/2025 |
5 | Wells Fargo Reaffirms Their Hold Rating on Cellectis SA - The Globe and Mail | 01/06/2026 |
6 | Individual investors invested in Cellectis S.A. copped the brunt of last weeks 35m market cap decline | 01/15/2026 |
| Begin Period Cash Flow | 136.7 M | |
| Total Cashflows From Investing Activities | -102.6 M |
Cellectis | Build AI portfolio with Cellectis Stock |
Cellectis Relative Risk vs. Return Landscape
If you would invest 535.00 in Cellectis SA on November 23, 2025 and sell it today you would lose (145.00) from holding Cellectis SA or give up 27.1% of portfolio value over 90 days. Cellectis SA is currently does not generate positive expected returns and assumes 4.5799% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of stocks are less volatile than Cellectis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cellectis Target Price Odds to finish over Current Price
The tendency of Cellectis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.90 | 90 days | 3.90 | about 82.57 |
Based on a normal probability distribution, the odds of Cellectis to move above the current price in 90 days from now is about 82.57 (This Cellectis SA probability density function shows the probability of Cellectis Stock to fall within a particular range of prices over 90 days) .
Cellectis Price Density |
| Price |
Predictive Modules for Cellectis
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cellectis SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cellectis Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cellectis is not an exception. The market had few large corrections towards the Cellectis' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cellectis SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cellectis within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.07 | |
β | Beta against Dow Jones | 0.55 | |
σ | Overall volatility | 0.48 | |
Ir | Information ratio | 0.01 |
Cellectis Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cellectis for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cellectis SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cellectis SA generated a negative expected return over the last 90 days | |
| Cellectis SA has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 41.51 M. Net Loss for the year was (36.7 M) with profit before overhead, payroll, taxes, and interest of 82.55 M. | |
| Cellectis SA has a frail financial position based on the latest SEC disclosures |
Cellectis Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cellectis Stock often depends not only on the future outlook of the current and potential Cellectis' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cellectis' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 90.6 M | |
| Cash And Short Term Investments | 260.3 M |
Cellectis Fundamentals Growth
Cellectis Stock prices reflect investors' perceptions of the future prospects and financial health of Cellectis, and Cellectis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cellectis Stock performance.
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.0447 | ||||
| Profit Margin | (0.43) % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 308.43 M | ||||
| Shares Outstanding | 72.59 M | ||||
| Price To Earning | (14.84) X | ||||
| Price To Book | 3.99 X | ||||
| Price To Sales | 4.86 X | ||||
| Revenue | 41.51 M | ||||
| Gross Profit | 82.55 M | ||||
| EBITDA | (9.46 M) | ||||
| Net Income | (36.7 M) | ||||
| Cash And Equivalents | 153.13 M | ||||
| Cash Per Share | 3.37 X | ||||
| Total Debt | 91.46 M | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 3.17 X | ||||
| Book Value Per Share | 1.39 X | ||||
| Cash Flow From Operations | 22.1 M | ||||
| Earnings Per Share | (0.33) X | ||||
| Market Capitalization | 401.36 M | ||||
| Total Asset | 383.54 M | ||||
| Retained Earnings | (329.61 M) | ||||
| Working Capital | 120.8 M | ||||
| Current Asset | 51 M | ||||
| Current Liabilities | 26.28 M | ||||
About Cellectis Performance
Assessing Cellectis' fundamental ratios provides investors with valuable insights into Cellectis' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Cellectis is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 4 K | 4.2 K | |
| Return On Tangible Assets | (0.09) | (0.09) | |
| Return On Capital Employed | (0.25) | (0.26) | |
| Return On Assets | (0.11) | (0.12) | |
| Return On Equity | (0.25) | (0.27) |
Things to note about Cellectis SA performance evaluation
Checking the ongoing alerts about Cellectis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cellectis SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cellectis SA generated a negative expected return over the last 90 days | |
| Cellectis SA has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 41.51 M. Net Loss for the year was (36.7 M) with profit before overhead, payroll, taxes, and interest of 82.55 M. | |
| Cellectis SA has a frail financial position based on the latest SEC disclosures |
- Analyzing Cellectis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cellectis' stock is overvalued or undervalued compared to its peers.
- Examining Cellectis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cellectis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cellectis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cellectis' stock. These opinions can provide insight into Cellectis' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.